Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies
Nedvídková, J.; Felt, V.
Casopis Lekaru Ceskych 123(27): 835-837
1984
ISSN/ISBN: 0008-7335 PMID: 6091888 Document Number: 226479
Document emailed within 1 workday
Related Documents
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Miyagi, Y. 1979: Guanosine 3', 5'-cyclic monophosphate level in plasma of patients with cancer and various diseases Bulletin of Tokyo Medical and Dental University 26(2): 81-84
Cayeux, S.J.; Beverley, P.C.; Schultz, R.; Dörken, B. 1993: Elevated post-stimulatory intracellular adenosine 3,5-cyclic monophosphate (cAMP) levels are found in peripheral blood cells after ABMT Bone Marrow Transplantation 11(6): 483-488
Xiao, X.C.; Tao, L.J. 2001: Assessment of dry body-weight in hemodialysis patients by plasma cyclic 3'5'-guanosine monophosphate Hunan Yi Ke da Xue Xue Bao 26(2): 133-135
Volicer, L.; Hurter, B.P. 1977: Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain Journal of Pharmacology and Experimental Therapeutics 200(2): 298-305
Widecka, K.; Krzyzanowska-Swiniarska, B.; Ciechanowski, K.; Goździk, J.; Czekalski, S. 1993: Plasma concentrations of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with hyperthyroidism before and after short-term treatment with methimazole Endokrynologia Polska 44(1): 65-71
Schmidt, M.J.; Sawyer, B.D.; Truex, L.L.; Marshall, W.S.; Fleisch, J.H. 1985: LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate Journal of Pharmacology and Experimental Therapeutics 232(3): 764-769
Reinert, M.; Biro, G. 1978: Plasma cortisol, cyclic adenosine monophosphate and lung function in asthmatic patients Münchener Medizinische Wochenschrift 120(29-30): 997-998
Zhikharev, S.S. 1977: Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma Terapevticheskii Arkhiv 49(3): 131-135
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Kul'chitskiĭ, O.K. 1980: Effect of acetylcholine on cyclic guanosine monophosphate levels in the hearts of rats of different ages Biulleten' Eksperimental'noi Biologii i Meditsiny 90(9): 318-319
Hunt, W.A.; Redos, J.D.; Dalton, T.K.; Catravas, G.N. 1977: Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol Journal of Pharmacology and Experimental Therapeutics 201(1): 103-109
Yang, Y.; Wang, W.-S.; Qiu, Y.; Sun, L.-H.; Yang, H. 2013: Role of cyclic adenosine monophosphate(cAMP) in the regulation of intestinal epithelial barrier function under hypoxia Zhonghua Wei Chang Wai Ke Za Zhi 16(5): 479-483
Weth, G. 1983: The influence of piracetam on the cyclic adenosine monophosphate (cAMP) concentration in the brain and colon of guinea pigs Arzneimittel-Forschung 33(6): 812-814
O'Callaghan, J.P.; Chess, Q.; McKimmey, C.; Clouet, D.H. 1979: The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system Journal of Pharmacology and Experimental Therapeutics 210(3): 361-367
Szücs, J.; Steczek, K. 1978: Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis Orvosi Hetilap 119(20): 1220-1224
Baksu, B.; Davas, I.; Baksu, A.; Akyol, A.; Gulbaba, G. 2005: Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 90(2): 112-117
Kuchel, O.; Messerli, F.H.; Tolis, G.; Hamet, P.; Fraysse, J.; Cartier, P.; Roy, P.; Boucher, R.; Genest, J. 1977: Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension Canadian Medical Association Journal 116(9): 992-996